Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1060 of 1,261
  1. US 7368534

    Myostatin and mimetics thereof

    ORICO LIMITED · Granted May 6, 2008 · Expires May 1, 2028

    granted
  2. US 7368100

    Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  3. US 7368468

    Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 6, 2008 · Expires May 1, 2028

    granted
  4. US 7368102

    Pulmonary delivery of aminoglycosides

    Nektar Therapeutics · Granted May 6, 2008 · Expires May 1, 2028

    granted
  5. US 7368110

    Antibodies, including Fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  6. US 7368114

    Fusion protein including of CD4

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  7. US 7368275

    In vivo incorporation of unnatural amino acids

    The Regents of the University of California · Granted May 6, 2008 · Expires May 1, 2028

    granted
  8. US 7368435

    Topical endoparasiticide and ectoparasiticide formulations

    Summit VetPharm, LLC · Granted May 6, 2008 · Expires May 1, 2028

    granted
  9. US 7368232

    High-throughput assay for virus entry and drug screening

    The Board of Regents of the University of Texas System · Granted May 6, 2008 · Expires May 1, 2028

    granted
  10. US 7368452

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 6, 2008 · Expires May 1, 2028

    granted
  11. US 7368106

    Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted
  12. US 7368463

    Substituted 4-amino-1-benzylpiperidine compounds

    Theravance, Inc. · Granted May 6, 2008 · Expires May 1, 2028

    granted
  13. US 7368606

    Amorphous cinacalcet hydrochloride and preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 6, 2008 · Expires May 1, 2028

    granted
  14. US 7368578

    Five-membered heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted May 6, 2008 · Expires May 1, 2028

    granted
  15. US 7368279

    Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 6, 2008 · Expires May 1, 2028

    granted
  16. US 7368257

    Modulators of lymphocyte activation, Mkk3b compositions and methods of use

    Rigel Pharmaceuticals, Inc. · Granted May 6, 2008 · Expires May 1, 2028

    granted
  17. US 7365165

    IL-1 antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  18. US 7364726

    Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

    The Regents of the University of California · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  19. US 7365171

    Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities

    Beijing Medical University United Biological Engineering Company · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  20. US 7365175

    Wit 3.0, a novel gene to control soft tissue wound healing

    The Regents of the University of California · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  21. US 7365096

    Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

    The Board of Regents of the University of Texas System · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  22. US 7365072

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  23. US 7365047

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    The Regents of the University of California · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted
  24. US 7365050

    Methods for modulating a drug-related effect or behavior

    The Regents of the University of California · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.